Heparan sulfate proteoglycans are important modulators of growth factor signaling in a variety of patterning processes. Secreted growth factors that play critical roles in angiogenesis bind to heparan sulfate, and this association is affected by 6-O-sulfation of the heparan sulfate chains. Addition of 6-O-sulfate is catalyzed by a family of sulfotransferases (HS6STs), and genetic manipulation of their function permits an assessment of their contribution to vascular assembly. We report on the biochemical activity and expression patterns of two zebrafish HS6ST genes. In situ hybridization reveals dynamic and distinct expression patterns of these two genes during development. Structural analysis of heparan sulfate from wild-type and morpholino antisense Fknockdown_ embryos suggests that HS6ST-1 and HS6ST-2 have similar biochemical activity. HS6ST-2, but not HS6ST-1, morphants exhibit abnormalities in the branching morphogenesis of the caudal vein during embryonic development of the zebrafish. Our finding that HS6ST-2 is required for the branching morphogenesis of the caudal vein is the first in vivo evidence for an essential role of a gene encoding a heparan sulfate modifying enzyme in vertebrate angiogenesis. Our analysis of two zebrafish HS6ST genes suggests that a wide range of biological processes may be regulated by an array of sulfation-modifying enzymes in the vertebrate genome. D
Introduction
Heparan sulfate proteoglycans (HSPGs) are present on the cell surface and in the extracellular matrix and play important roles in a variety of biological processes such as cell adhesion, wound healing and microbial pathogenesis (Rosenberg et al., 1997; Bernfield et al., 1999; Rapraeger, 2001) . Each heparan sulfate chain attached to the protein core of an HSPG is composed of alternating d-glucuronic acid (GlcA) and N-acetyl-d-glucosamine units. N-sulfation of a proportion of the disaccharides occurs in blocks often referred to as S-domains. Within the S-domains other modifications take place, such as epimerization of GlcA to l-iduronic acid, sulfation at the 2-O position of uronic acid, or the 3-O position and the 6-O position of glucosamine. The sulfation pattern within the S-domains, as well as their length and spacing, contribute to the structural heterogeneity of heparan sulfate and may create specific binding sites for protein ligands (Esko and Selleck, 2002) .
The interaction of heparan sulfate with protein ligands is often essential for modulating ligand-receptor binding and can influence the outcome of downstream signaling events (Perrimon and Bernfield, 2000; Esko and Selleck, 2002; Nakato and Kimata, 2002) . The developmental abnormalities found in mutants deficient in the function of heparan sulfate biosynthetic enzymes have demonstrated the importance of heparan sulfate fine structure in regulating a variety of patterning and morphogenetic events in many organisms. For example, mice homozygous for a gene trap mutation in Hs2st show renal agenesis, eye and skeletal defects (Bullock et al., 1998) . RNA interference of the Drosophila HS6ST gene produces defective branching in the tracheal system, a developmental system that shares many of the signaling components required for vertebrate angiogenesis (Kamimura et al., 2001) .
In vitro studies have implicated heparan sulfate 6-O sulfation as a critical regulatory step in vessel formation. For example, 6-O desulfated heparin abolishes the amplifying effect of heparin on FGF-2 activation of FGFR-1 signaling and also inhibits FGF-2 induced angiogenesis (Lundin et al., 2000) . The specific arrangement of 6-O-sulfated disaccharide units within heparan sulfate plays an important role in the binding of Endostatin, a peptide inhibitor of angiogenesis that requires heparan sulfate for its anti-angiogenic effect (Blackhall et al., 2003) . While these in vitro studies suggest an important role for 6-O modification of heparan sulfate in vascular assembly, the functional requirement for this structural modification of HS in vivo is not known. We are using the zebrafish as a vertebrate model system to address the role of 6-O sulfation in vascular development, a highly conserved vertebrate developmental process (Roman and Weinstein, 2000; Weinstein, 2002) . In contrast to mammals, passive diffusion of oxygen can sustain survival of zebrafish embryos without functional vasculature. This advantage permits the identification of genes essential for different stages of vascular development.
In this study, we have examined the function and expression of two zebrafish heparan sulfate 6-O sulfotransferase (HS6ST) genes, HS6ST-1 and HS6ST-2. The HS6ST-2 gene was originally identified from a morpholino-based screen for genes affecting vascular assembly and function in zebrafish, and its role in muscle development has been previously characterized by Bink et al. (2003) . Using morpholino anti-sense oligonucleotides to inhibit HS6ST-1 and -2 function, we show that these two proteins are required for normal patterns of 6-O sulfation. HS6ST-1 and HS6ST-2 display distinct expression patterns in vivo. HS6ST-2 is expressed in the region around the caudal vein, and HS6ST-2 morphant embryos show defects in the branching morphogenesis of the caudal vein, defects which were not observed in HS6ST-1 morphant embryos. The finding that HS6ST-2 is essential for the branching morphogenesis of the caudal vein in zebrafish is the first evidence for an in vivo role of a HS6ST in vascular development of a vertebrate system.
Materials and methods

Morpholino sequences and injections
The HS6ST-1 and HS6ST-2 morpholino phosphorodiamidate oligonucleotides (morpholinos), from Gene Tools, LLC, have the following sequences:
All were designed against the corresponding cDNA (see GenBank accession numbers below). All morpholinos were prepared and injected as previously described . HS6ST-2 MO #1 is identical to the HS6ST MO #1 described by Bink et al. (2003) and HS6ST-2 MO #2 is shifted one base 5Vof their second HS6ST-2 targeted morpholino. VEGF-A morpholinos are from .
Raising and staging embryos
Embryos were raised at 29-C. Zebrafish embryos were staged using standard morphological criteria (Kimmel et al., 1995) prior to fixation and analysis to compensate for any observed developmental delay.
Microangiography analysis
For microangiography analysis, tetramethylrhodamine isothiocyanate (TRITC)-dextran dye was dissolved in 0.3 Â Danieau buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO 4 , 0.6 mM (CaNO 3 ) 2 , 5.0 mM HEPES pH 7.6) at 20 mg/ml and was microinjected into the common cardinal vein of Tg(fli-1:EGFP) embryos as previously described . The fli-1:EGFP-labeled vasculature and the microangiograms were visualized using the FITC and the TRITC filter sets as previously described (Finley et al., 2001 ).
Cloning of zebrafish HS6ST-1 and HS6ST-2
The full-length coding sequence for zebrafish HS6ST-1 and HS6ST-2 was determined by standard sequencing of EST clones obtained from Incyte Genomics. The cDNA sequences were submitted to GenBank (HS6ST-1: AY575770; HS6ST-2: AY575769).
HS6ST-1 MO #1: 5V-TCCAGTGAGGAGGTTCATGTGT-TAC-3V HS6ST-1 MO #2: 5V-GTTGACTGTTTTTTAGGGT-GTCTCC-3V HS6ST-2 MO #1: 5V-GATTTCCCATCCATCTTCTC-GCTGG-3V HS6ST-2 MO #2: 5V-AGTGAAAGCATTACTCGGTT-GTGCG-3V VEGF-A MO: 5V-GTATCAAATAAACAACCAAGTTCAT-3V VEGF-A MOd4 (four-base mismatches are in lower-case):
5V-GTAaCAAtTAAACAACCAtGTTgAT-3V
Expression constructs and injections
A SpeI site was introduced at the 5Vand the 3Vends of the zebrafish HS6ST-1 and HS6ST-2 coding sequence by PCR, using the EST clones as the DNA template. The PCR fragment was subsequently subcloned into the SpeI site of the FRM expression construct (Gibbs and Schmale, 2000) . DNA-based rescue of morpholino-induced defects was conducted using the methods essentially as previously described for syndecan-2 (Chen et al., 2004) . The solution of the test DNA construct mixed with FRM-DsRed expression construct was injected into 1-cell embryos at the interface between the yolk and the blastomere to ensure uniform mosaic distribution (Finley et al., 2001 ). The FRMDsRed expression construct is used as a lineage tracer to facilitate the selection of embryos showing mostly uniform mosaic expression.
Preparation and HPLC analysis of heparan sulfate disaccharides
This protocol was adapted from Toyoda et al. (2000) and Ledin et al. (Unpublished, Uppsala University, Sweden) . Samples of 100, 48 hpf dechorionated zebrafish were washed in distilled water and lyophilized, then resuspended in 0.5 ml 50 mM Tris/HCl pH 8, 1 mM CaCl 2 , 1% Triton-X100. The samples were sonicated three times for 30 s at 4 -5 W before removal of a fraction of material for protein estimation (Pierce BCA Assay). Samples were then digested with 0.8 mg/ml protease for 16 h at 55-C, heat inactivated at 96-C for 5 min, then incubated 2 h at 37-C with 1 Al 1 M MgCl 2 and 0.5 Al (168.5 U) benzonase. NaCl was added to 0.1 M and insoluble material removed by microcentrifugation for 10 min at 16,000Âg. The solution was applied on a Vivapure Mini D membrane (Sartorius AG, Germany), which had been equilibrated with sodium phosphate buffer (pH 6.0) containing 0.15 M NaCl. The fractions eluted with 1.0 M NaCl in the same buffer were collected, desalted with Biomax-5 (Millipore, Billerica, MA) filtration column, lyophilized and resuspended in 15 Al 0.03 M sodium acetate buffer (pH 7.0) with 3.33 mM calcium acetate, 0.33 mIU heparinase, 0.33 mIU heparitinase II and 0.33 mIU heparitinase I (Seikagaku America, East Falmouth, MA). The mixture was incubated at 37-C for 16 h, lyophilized and resuspended in 12 Al water to load onto the HPLC. HPLC conditions were as Toyoda et al., 2000 .
In situ hybridization
A BglII site was introduced at the 5Vand the 3Vends of the zebrafish HS6ST-2 coding sequence by PCR, and the DNA fragment was subcloned into the BglII site of T3TS (Hyatt and Ekker, 1999) . The plasmid was linearized with SpeI and T3 polymerase was used for DIG-labelled antisense RNA synthesis. The PCR fragment containing the open reading frame of HS6ST-1 was subcloned into the TOPO vector (Invitrogen). The plasmid was linearized with SpeI, and T7 polymerase was used for DIG-labelled antisense RNA synthesis. DIG-labelled probes were synthesized using the in vitro DIG labelling kit (Roche). The in situ hybridization procedure was performed essentially as described (Jowett, 1999) .
Results
In our ongoing morpholino-based screen to identify novel genes essential for vascular development in the zebrafish, Danio rerio, we characterized vascular defects in embryos injected with morpholinos against a gene fragment with similarity to vertebrate HS6ST proteins. Upon full sequencing of the target cDNA (Fig. 1A) and subsequent phylogenetic analysis (Fig. 1C) , the gene target was later identified as a zebrafish HS6ST-2 family member. From the zebrafish EST database, one other HS6ST-related gene was identified. Sequence ( Fig. 1B ) and phylogenetic analysis ( Fig. 1C ) of the full-length coding sequence for this Phylogenetic tree of vertebrate HS6ST proteins assembled using CLUSTAL analysis (Macvector 7.2.3 software). The value at each branch denotes the mean number of differences per residue along each branch (Thompson et al., 1994) . Human HS6ST-2 S is an alternate isoform of HS6ST-2 .
additional HS6ST gene indicates that this is a zebrafish HS6ST-1 family member. We have conducted subsequent analyses of the EST and genomic databases, and we have identified fragments of sequence that code for possibly two additional members of the zebrafish HS6ST gene family; sequence coverage is, however, not sufficient to unambiguously assign likely orthology (data not shown).
The embryonic expression pattern of HS6ST-1 is distinct from that of HS6ST-2 in zebrafish
To determine whether zebrafish HS6ST-1 and HS6ST-2 might have distinct biological roles, in situ hybridization was conducted to compare spatial expression patterns during development. A previous report by Bink et al. (2003) demonstrated expression of HS6ST-2 in the brain during somitogenesis and at 24 h post-fertilization (hpf) and also in the fin buds at 48 hpf (Bink et al., 2003) . Here, we show that expression of HS6ST-2 is also detected in the caudal wave of maturing somites from the 4-somite stage to the 18 somite-stage (arrowheads in Figs. 2A -C and data not shown). At the 22-somite stage, HS6ST-2 is detected in a stripe of cells in ventral medial somites ( Fig. 2D ) and persists through 24 hpf (Fig. 2E) . A transverse section through the caudal region of an embryo at 24 hpf indicates expression of HS6ST-2 in the ventral medial somites and cells surrounding the vascular structures of the dorsal aorta and caudal vein in the tail (area of expression outlined by dash lines in Fig. 2F ).
Similar to HS6ST-2 ( Fig. 2E ), HS6ST-1 is also strongly expressed in the eyes during somitogenesis (Figs. 2G -H). In contrast to HS6ST-2, localized expression of HS6ST-1 mRNA in the brain is detected during somitogenesis, at 24 hpf and 33 hpf (Figs. 2I -K), and its expression is not detected in the vasculature.
Analysis of heparan sulfate composition of HS6ST morphants
To determine if HS6ST-1 and HS6ST-2 function affects the structural modifications of heparan sulfate in vivo, glycosaminoglycans were isolated from wild-type, bufferinjected and morpholino-injected embryos. The partially purified heparan sulfate was digested with heparin lyases into disaccharides. The disaccharides were then separated by reverse phase ion pair HPLC and labeled with postcolumn fluorescent derivatization. The peaks were identified by their elution time compared to that of known heparan sulfate disaccharide standards. Six disaccharide species, including three 6-O sulfated disaccharides, DUAGlcNAc6S, DUA-GlcNS6S and DUA2S-GlcNS6S, (see Fig. 3 legend for key to abbreviations) were present in wild-type, buffer-injected, and morpholino-injected embryos (Fig. 3, data not shown) . Two of the three 6-O sulfated disaccharides, DUA-GlcNAc6S and DUAGlcNS6S (peaks 3 and 4, Fig. 3B ), were significantly reduced in both HS6ST-1 MO-and HS6ST-2 MO-injected embryos compared to wild-type embryos (see Table 1 ). The relatively modest changes observed with morpholino knockdown of either HS6ST-1 or HS6ST-2 are possibly due to functional redundancy between HS6ST genes in zebrafish, of which only one was targeted at a time. When both HS6ST-1 and HS6ST-2 genes were simultaneously targeted using a reduced dosage inhibition protocol to allow embryo viability, there was no additional decrease in the 6-O-sulfated disaccharides (data not shown). This result suggests that there are other HS6ST genes in the zebrafish that may be able to compensate for the remaining 6-O sulfotransferase function. The limited effects of the morpholinos may also be attributed to the low doses that were used to avoid any non-specific toxicity. There was no change in HS-derived disaccharides from buffer-injected embryos compared to wild-type controls indicating the changes observed in heparan sulfate composition were not a result of stress to the embryo due to the injection (Table  1) . These results suggest that both HS6ST-1 and HS6ST-2 can sulfate similar disaccharide species, although these disaccharides may be present within a different oligosaccharide sequence, since the disaccharide profiling does not provide information concerning the structural context of any given disaccharide.
HS6ST-2 MO-injected embryos showed defective morphogenesis of the caudal vein
In our morpholino-based screen, an EGFP transgenic line (fli-1:EGFP) was used to assess vascular development. In Tg(fli-1:EGFP) embryos, the fli-1 promoter drives the expression of the EGFP reporter in endothelial cells that line the blood vessels (Lawson and Weinstein, 2002) . At 24 hpf, no apparent vascular defects were observed in HS6ST-2 MO-injected embryos. Beginning around 30 hpf, however, HS6ST-2 MO-injected Tg(fli-1:EGFP) embryos showed defective formation of the venous plexus, the network of microvessels derived from the caudal vein (CV) (Fig. 4) . In the less severe case, HS6ST-2 MO-injected embryos displayed reduced branching of the CV. Instead of the fine meshwork of the CV observed in uninjected wild-type embryos, HS6ST-2 MO-injected embryos exhibited the formation of large loops in the CV plexus (arrowheads in Fig. 4C ). In the more severe case, HS6ST-2 MO-injected embryos showed a lack of branching and instead formed disorganized and over-lumenized vessels in place of the venous plexus (arrowheads in Fig. 4E ). In contrast, no vascular defects were observed in embryos injected with the HS6ST-1 morpholino at a dose where a change in the 6-O sulfation profile was observed ( Fig. 3 and Table 1) , consistent with the lack of HS6ST-1 expression in the developing vasculature. The expression of HS6ST-1 in the developing eyes and the central nervous system suggest that HS6ST-1 may play a role in other biological functions during development.
To assess the functional integrity of the vasculature (for example, leakiness of vessel walls and lumen patency), microangiography was conducted on HS6ST-2 MO-injected embryos using TRITC-dextran. Functional circulation was observed in HS6ST-2 MO-injected embryos showing reduced branching morphogenesis of the CV (Fig. 4D) . In the most severe case, pooling of TRITC-dextran was observed in the cavernous vessels that lack any branching morphology (Fig. 4F) .
To assess whether the defective morphogenesis of the CV was specific to the loss of HS6ST-2 function, we showed that two gene-specific morpholinos of independent sequence generated similar defects in the plexus of the CV including the formation of large loops in the plexus and enlarged vascular channels (Fig. 4G) . In contrast, injection of HS6ST-1 MO at a similar dose range did not generate a significant percentage of embryos with caudal vein defects (compare column 3 to columns 1 and 2 in Fig. 4G ). We Fig. 3 . Heparan sulfate disaccharide profiling of HS6ST-1 and HS6ST-2 morphant embryos. (A) Representative HPLC chromatograms of wild-type (black), 5 ng HS6ST-2 morpholino-injected (blue) and 2 ng HS6ST-1 morpholino-injected (red) embryos. Six disaccharides were identified: peak 1: DUA-GlcNAc, D4,5 unsaturated hexuronate-N-acetyl glucosamine; peak 2: DUA-GlcNS, DUA-N-sulfated glucosamine; peak 3: DUA-GlcNAc6S, DUA-6-O-sulfated GlcNAc; peak 4: DUA-GlcNS6S, DUA-6-O-sulfated GlcNS; peak 5: DUA2S-GlcNS, DUA2-O-sulfated GlcNS; peak 6: DUA2S-GlcNS6S. (B) Boxed region of (A). Arrows represent the two 6-O sulfated disaccharides, peak 3 and peak 4, which are reduced in HS6ST-1 and HS6ST-2 morpholino-injected embryos. (C) Graphical depiction of disaccharide composition in wild-type (black), HS6ST-2 (blue) and HS6ST-1 (red) morpholino-injected embryos, represented as percent of total heparan sulfate. Inset is close up of peaks 3 and 4, DUA-GlcNAc6S and DUA-GlcNS6S, respectively. Asterisks indicate significant changes from wild-type (t test P < 0.05 with HS6ST-1 peak 3 P < 0.001). also asked whether the introduction of the HS6ST-2 protein would alleviate the vascular defects observed in HS6ST-2 MO-injected embryos. A mixed solution of HS6ST-2 DNA expression construct that does not contain the HS6ST-2 MO binding site and a DsRed construct was co-injected with HS6ST-2 MO into Tg(fli-1:EGFP) embryos. DsRed is introduced as a tracer to facilitate the identification of DNA-injected embryos (Fig. 5D ). In this method, DNA injection results in the mosaic distribution of inherited DNA in these embryos (Fig. 5D ). Compared to embryos injected with the HS6ST-2 MO alone, a higher frequency of the co-injected embryos showed normal formation of the caudal vein plexus (Fig. 5F , compare the second column to the first columns, P < 0.0005). In co-injected embryos, HS6ST-2-expressing cells correlated with regions in the restored venous plexus (Fig. 5E ). In contrast, co-injection of a control expression construct did not affect the frequency of vascular defects in HS6ST-2 MO-injected embryos (Fig. 5F , compare column 3 to column 1, P > 0.2). These results indicate that the venous defects observed in embryos injected with HS6ST-2 MO are specific to the loss of HS6ST-2 function.
HS6ST-2 is required for somite development
A previous report by Bink et al. (2003) has demonstrated that zebrafish HS6ST-2 plays a role during the late stage of anterior somite patterning as indicated by the reduced expression of mesp-b, a bHLH transcription factor upstream of notch5 and notch6 in zebrafish, in HS6ST-2 morphant embryos. HS6ST-2 is also essential for proper muscle differentiation. In wild-type embryos, high expression of myoD is only detected in posterior-most somites at 24 hpf. In contrast, myoD expression remains upregulated in all somites of HS6ST-2 morphant embryos at 24 hpf (Bink et al., 2003) . We have also observed similar alterations in the expression of mesp-b (34% T 7%, n = 49, TSEM) and myoD (67% T 17%, n = 46, TSEM), supporting the role of HS6ST-2 in muscle development. These noted defects in somitogenesis correlate with the somitic wave of HS6ST-2 expression during segmentation ( Figs. 2A -E) .
Expression of late endothelial markers is reduced in HS6ST-2 morphants
To assess the nature of the vascular defects in HS6ST-2 morphants, in situ hybridization was conducted to analyze expression of endothelial markers in HS6ST-2 morphants during vascular development. Expression of flk-1, which encodes a Vascular Endothelial Growth Factor (VEGF) receptor, is first detected in bilateral stripes of endothelial precursor cells during early somitogenesis and becomes localized to the endothelium of developing blood vessels from late somitogenesis to about 36 hpf (Fouquet et al., 1997) . Compared to uninjected wild-type embryos, flk-1 expression was normal in HS6ST-2 morphants at 24 hpf (Fig. 6B) , indicating that the primary formation of the axial vessels and initial sprouting of intersegmental vessels proceed normally in HS6ST-2 morphants.
In a zebrafish embryo, branches from the developing caudal vein are observed at 30 hpf and form a plexus up to 40 hpf. The caudal vein is subsequently remodeled to form a single vascular tube by day 5 post-fertilization (Isogai et al., 2001; Huang et al., 2003) . The vascular markers, tie-1 and tie-2, are expressed in the endothelium of the vasculature undergoing this angiogenic remodeling process (Lyons et al., 1998) . Expression domains of tie-1 and tie-2 were reduced in the developing caudal vein of HS6ST-2 MOinjected embryos at 30 hpf (arrowheads in Fig. 6D and data not shown; compare to uninjected control, Fig. 6C ) and at 48 hpf (data not shown). These results indicate that the venous defects observed in HS6ST-2 morphants occur during latter stages of vascular development in zebrafish embryos.
HS6ST-2 and VEGF interact in vivo during caudal vein plexus formation
VEGF-A is one of several heparin-binding growth factors that play an essential role in angiogenesis. To assess for an in vivo interaction between HS6ST-2 and VEGF-A during caudal vein plexus formation, morpholinos against HS6ST-2 and VEGF-A were co-injected into embryos using doses that alone elicited only minimal effects on venous column 4). These results suggest that HS6ST-2 and VEGF-A interact in vivo during caudal vein formation.
Discussion
The specific sulfation pattern of heparan sulfate is essential for its ability to interact with a variety of heparinbinding growth factors involved in angiogenesis. While 6-O sulfation has been implicated in vessel formation in vitro (Lundin et al., 2000) , the in vivo function of 6-O sulfation in vascular development is poorly understood. In this study, we have used zebrafish as a vertebrate model system to understand the role of 6-O sulfation in vascular development. We have examined the function of two HS6ST genes, HS6ST-1 and HS6ST-2. Structural analyses of heparan sulfate disaccharides isolated from HS6ST-1 and HS6ST-2 morphants indicated that these two enzymes are required for the normal 6-O sulfation pattern of heparan sulfate. HS6ST-1 and HS6ST-2 display distinct expression patterns. HS6ST-2 is expressed in the region of the developing caudal vein and is required for the branching morphogenesis of the caudal vein. This study provides the first in vivo evidence of a heparan sulfate modifying gene, HS6ST-2, being essential for vascular development.
Distinct expression patterns and functions for HS6ST-1 and HS6ST-2
In situ hybridization revealed dynamic, highly localized expression patterns of HS6ST-1 and HS6ST-2 during development. The expression of HS6ST-2 in the cells surrounding the dorsal aorta and posterior cardinal vein suggested that it might have a role in vascular development or function. This was substantiated by the reduced The test DNA (HS6ST-2 expression construct) or the control DNA (DsRed expression construct) was injected into embryos separately injected with HS6ST-2 MO2. The introduction of HS6ST-2 protein by the DNA injection alleviates the caudal vein defects in HS6ST-2 MO2-injected embryos (compare column 2 to column 1). Asterisk (*) denotes statistical significance with P < 0.0005. In contrast, a separate injection of control DNA into HS6ST-2 MO2-injected embryos does not affect the frequency of caudal vein defects in HS6ST-2 MO2-injected embryos (compare column 3 to column 1; P > 0.2). N indicates the total number of embryos scored. TSEM.
branching complexity in the caudal vein plexus observed in HS6ST-2 morphants. Our analysis of HS6ST-2 expression in the developing somites also supports a role in muscle development, as previously proposed (Bink et al., 2003) . In contrast, morpholino knockdown of HS6ST-1 did not affect vascular development, and its expression pattern indicates that it may be important for eye and brain development.
Compositional analysis of heparan sulfate from HS6ST morpholino antisense knockdown embryos Biochemical analysis of heparan sulfate from morphant embryos demonstrated that both HS6ST-1 and HS6ST-2 affect 6-O-sulfation of both N-sulfoglucosamine and N-acetyl glucosamine. In contrast, cell free assays of HS6STs (Habuchi et al., 2000 Bink et al., 2003) suggested that these enzymes exhibit poor activity towards N-acetyl glucosamine (Habuchi et al., 2000) . Similarly Bink et al. (2003) observed very little sulfation of N-acetyl glucosamine by zebrafish HS6ST-2 extracted from COS-7 cells. In vivo analysis, however, from our study and that of Bink et al. (2003) suggest that HS6STs can affect 6-O sulfation of N-acetyl glucosamine. Compared to Bink et al. (2003) , we noted less of a decrease in the disaccharide DUA-GlcNS6S and no significant decrease in DUA2S-GlcNS6S upon morpholino knockdown of HS6ST-2, perhaps due to our use of only one of the two morpholino sequences they used or to possible strain/staging specific differences in the wild-type disaccharide profiles. Interestingly, in both studies, the level of DUA2S-GlcNS6S, found to be critical for heparan sulfate binding of a number of proteins (Feyzi et al., 1997; Parthasarathy et al., 1994) , was preserved to a greater extent than the other 6-O-sulfated disaccharides in the morphant embryos. This may represent a mechanism to retain specific ligand binding properties of heparan sulfate at low enzyme levels. It is likely that the recognition site for the HS6STs in vivo is more complex than the individual substrate disaccharide type, and its activity depends on the surrounding sequence having the correct structural features (Zhang et al., 2001 , Jemth et al., 2003 ). Although we were not able to detect disaccharide type specificity for zebrafish HS6ST-1 and HS6ST-2, their substrate recognition sites may be unique to the heparan sulfate of the separate tissues in which they are expressed. Our results suggest that the tissue-specific expression of the HS6STs may contribute to their unique biological functions.
Analysis of the role of HS6ST-2 in angiogenesis
In this study, the role of HS6ST-2 in angiogenesis is explored. As the primary vasculature is laid down in a vertebrate embryo, the primitive network of blood vessels undergoes a series of remodeling steps to form mature vasculature, which is further stabilized by the recruitment of smooth muscle cells and other supporting cells (Carmeliet, 2000) . Reduced expression domains of the late endothelial markers tie-1 and tie-2 in the caudal vein during the time period of remodeling indicate that HS6ST-2 is important for development of the vasculature in this region. This result correlates with the reduced branching complexity of the caudal vein plexus observed in the HS6ST-2 morphant Tg(fli-1:EGFP) embryos and the location of HS6ST-2 Fig. 6 . Expression of late endothelial markers in the region of forming venous plexus is reduced in HS6ST-2 morphants. Expression of flk-1 as shown by whole-mount in situ hybridization in a wild-type embryo (A) and a HS6ST-2 MO-injected embryo (B) at 24 hpf. Normal expression of flk-1 is observed in HS6ST-2 MO-injected embryos at 24 hpf (n = 19). However, at 30 hpf, the expression domain of the late endothelial marker, tie-1 (D; 81% T 8%, n = 40, TSEM) is reduced in the region of caudal vein (area indicated by brackets and arrowheads) in HS6ST-2 MO-injected embryos compared to wild-type embryos (C).
expression at similar time points of angiogenic remodeling. The caudal vein plexus is a paradigm for studying the complexity of vertebrate angiogenesis because first it expands and then is gradually remodeled to form a single vascular tube (Isogai et al., 2001) . The caudal vein phenotype we observed in the HS6ST-2 morphants is similar to that of reg6 zebrafish mutants, which also display defects in the branching morphogenesis of the caudal vein (Huang et al., 2003) . This suggests that HS6ST-2 plays an essential role in the remodeling process of the caudal vein plexus. However, we cannot exclude the possibility that defective muscle differentiation in HS6ST-2 morphant embryos may contribute to the defects of the venous plexus observed.
Role of HS6STs in branching morphogenesis
A number of studies have also provided evidence that 6-O-sulfated heparan sulfate may be important for the precise localization and activity of secreted modulators of branching morphogenesis. HS6STs are necessary for FGFdependent branching morphogenesis in the Drosophila tracheal system and the mammalian lung (Kamimura et al., 2001; Izvolsky et al., 2003) . In both cases, 6-O-sulfation is experiments is shown. Embryos co-injected with HS6ST-2 MO2 (0.5 ng) and VEGF-A MO (1 ng) exhibit a more than additive increase in the frequency (TSEM) of embryos with branching defects in the caudal vein plexus (column 3) compared to embryos injected with HS6ST-2 MO2 or VEGF-A MO only. In contrast, no synergy is observed in the embryos co-injected with HS6ST-2 MO and a four-base mismatch MO (d4, 1 ng) against VEGF-A (column 4). predominantly in the FGF target cells, supporting its proposed requirement for FGFR activation (Pye et al., 1998; Ostrovsky et al., 2002) . Spatial and temporal variance of heparan sulfate structure has been shown to facilitate assembly of specific FGF -FGFR pairs (Allen and Rapraeger, 2003) . Normal vascular branch formation requires the heparin-binding sites of VEGF-A, (Ruhrberg et al., 2002) , another ligand of 6-O-sulfated heparan sulfate (Ono et al., 1999) . The ability to bind heparan sulfate has been shown to be necessary to spatially restrict VEGF to regulate vascular branching pattern (Ruhrberg et al., 2002) .
We have observed a synergy between the HS6ST-2 MO and the VEGF-A MO in generating embryos with defective branching in the caudal vein, suggesting that HS6ST-2 and VEGF-A interact during angiogenesis in vivo. As HS6ST-2 is expressed in the cells surrounding the caudal vein plexus, it is possible that the changes in the heparan sulfate modifications on the cell surface or in the extracellular matrix, induced by HS6ST-2, influence VEGF signaling by modulating the bioavailability of VEGF in the regions of the venous plexus. Another possibility is that the changes in the heparan sulfate profile induced by HS6ST-2 affect the signaling activity of other heparin-binding growth factors and in turn influence VEGF-mediated signaling. It remains to be investigated whether HS6ST-2 expression in the caudal vein plexus is important for regulating the activity of FGF or one of the many other ligands of heparan sulfate (Esko and Selleck, 2002) .
In conclusion, we have demonstrated that HS6ST-1 and HS6ST-2 display distinct expression profiles and that HS6ST-2 has a unique role in vascular development. Previous in vivo studies have shown diverse roles for specific sulfate modifications of heparan sulfate in a variety of biological processes including axon guidance (Bulow and Hobert, 2004) and kidney development (Bullock et al., 1998) . The results described here support the hypothesis that regulation of the sulfation pattern of heparan sulfate is a fine control mechanism of many physiological processes. Our finding that HS6ST-2 is essential for the branching morphogenesis of the caudal vein is the first in vivo evidence for a role of a specific heparan sulfate modifying enzyme in vertebrate angiogenesis. This result advocates the therapeutic benefit of agents controlling heparan sulfate modification to ameliorate a number of disorders that involve pathological angiogenesis, including tumor growth, diabetic retinopathy and coronary heart disease.
